2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Rehabilitation
Cancer rehabilitation is an integral part of holistic cancer care, dedicated to enhancing survivors' overall well-being through physical, emotional, and social interventions. Current research highlights the necessity of individualized rehabilitation programs tailored to the distinct needs of cancer patients. These initiatives typically encompass physical therapy to alleviate fatigue and improve mobility, occupational therapy to boost everyday functional abilities, and psychological counseling to address the mental health challenges posed by a cancer diagnosis and its treatment. Technological advancements, such as tele-rehabilitation and mobile health apps, are increasingly being utilized to deliver accessible, customized care. Furthermore, recent studies underscore the significance of exercise and nutrition in reducing treatment side effects and fostering long-term health. With rising survival rates, cancer rehabilitation is vital in helping survivors achieve a high quality of life after treatment.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China